An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma.

Autor: de Jong MME; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Fokkema C; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Papazian N; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Czeti Á; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Appelman MK; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Vermeulen M; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van Heusden T; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Hoogenboezem RM; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van Beek G; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Tahri S; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Sanders MA; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van de Woestijne PC; Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Gay F; Clinical Trial Unit, Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Moreau P; Department of Hematology, Nantes University Hospital Hotel-Dieu, Nantes, France., Büttner-Herold M; Department of Internal Medicine 5, Hematology and Oncology, Friedrich Alexander University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany., Bruns H; Department of Internal Medicine 5, Hematology and Oncology, Friedrich Alexander University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany., van Duin M; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Broijl A; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Sonneveld P; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands. p.sonneveld@erasmusmc.nl., Cupedo T; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands. t.cupedo@erasmusmc.nl.

Publikováno v: Nature immunology [Nat Immunol] 2024 May; Vol. 25 (5), pp. 820-833. Date of Electronic Publication: 2024 Apr 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of crosslinking on morphology and phase inversion of EPDM/PP blends

Autor: Antunes, C.F., van Duin, M., Machado, A.V.

Publikováno v: In Materials Chemistry and Physics 15 March 2012 133(1):410-418

Di-azides cross-linked, iPP/EPDM-based thermoplastic vulcanizates

Autor: Zielińska, A.J., Noordermeer, J.W.M., Talma, A.G., van Duin, M.

Publikováno v: In European Polymer Journal 2011 47(12):2311-2320

Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?

Autor: D'Agostino M; SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Terragna C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., van Duin M; Department of Haematology, Erasmus Medical Center, Rotterdam, Netherlands.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Jul 31; Vol. 13, pp. 1247808. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).